Translating Asthma Pharmacogenomics into Practice: Evidence Synthesis, Clinical Implementation, and Future Directions
Asthma Allergy Immunology · 29.04.2026 · 24 (1) · 13-25
DOI: 10.21911/aai.2026.1162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asthma Allergy Immunology, online erschienen am 29.04.2026. Verfasst von Sheetal BUDDHADEV und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
BUDDHADEV, S., PRAJAPATI, B., GADAVALA, S., KAYAMBO, D., & VEDIYA, P. (2026). Translating Asthma Pharmacogenomics into Practice: Evidence Synthesis, Clinical Implementation, and Future Directions. Asthma Allergy Immunology, 24(1), 13-25. https://doi.org/10.21911/aai.2026.1162
Vancouver
BUDDHADEV S, PRAJAPATI B, GADAVALA S, KAYAMBO D, VEDIYA P. Translating Asthma Pharmacogenomics into Practice: Evidence Synthesis, Clinical Implementation, and Future Directions. Asthma Allergy Immunology. 2026;24(1):13-25. doi:10.21911/aai.2026.1162
BibTeX
@article{BUDDHADEV2026,
author = {BUDDHADEV, Sheetal and PRAJAPATI, Bhupendra and GADAVALA, Sarah and KAYAMBO, Denis and VEDIYA, Pratik},
title = {Translating Asthma Pharmacogenomics into Practice: Evidence Synthesis, Clinical Implementation, and Future Directions},
journal = {Asthma Allergy Immunology},
year = {2026},
volume = {24},
number = {1},
pages = {13--25},
doi = {10.21911/aai.2026.1162}
}
EUVIMED